Folgen
Ganesh Palapattu
Ganesh Palapattu
Bestätigte E-Mail-Adresse bei med.umich.edu
Titel
Zitiert von
Zitiert von
Jahr
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium
SF Shariat, PI Karakiewicz, GS Palapattu, Y Lotan, CG Rogers, GE Amiel, ...
The Journal of urology 176 (6), 2414-2422, 2006
8442006
Prostate carcinogenesis and inflammation: emerging insights
GS Palapattu, S Sutcliffe, PJ Bastian, EA Platz, AM De Marzo, WB Isaacs, ...
Carcinogenesis 26 (7), 1170-1181, 2005
5292005
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer
ME Allaf, GS Palapattu, BJ Trock, HB Carter, PC Walsh
The Journal of urology 172 (5), 1840-1844, 2004
4252004
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy
SF Shariat, GS Palapattu, PI Karakiewicz, CG Rogers, A Vazina, ...
European urology 51 (1), 137-151, 2007
4082007
The PSA−/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration
J Qin, X Liu, B Laffin, X Chen, G Choy, CR Jeter, T Calhoun-Davis, H Li, ...
Cell stem cell 10 (5), 556-569, 2012
3662012
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at …
Y Lotan, A Gupta, SF Shariat, GS Palapattu, A Vazina, PI Karakiewicz, ...
Journal of clinical oncology 23 (27), 6533-6539, 2005
3452005
Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma
GS Palapattu, B Kristo, J Rajfer
Reviews in urology 4 (4), 163, 2002
3042002
Nomograms provide improved accuracy for predicting survival after radical cystectomy
SF Shariat, PI Karakiewicz, GS Palapattu, GE Amiel, Y Lotan, CG Rogers, ...
Clinical Cancer Research 12 (22), 6663-6676, 2006
2852006
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder
PI Karakiewicz, SF Shariat, GS Palapattu, AE Gilad, Y Lotan, CG Rogers, ...
The Journal of urology 176 (4), 1354-1362, 2006
2492006
Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy
PJ Bastian, GS Palapattu, X Lin, S Yegnasubramanian, LA Mangold, ...
Clinical cancer research 11 (11), 4037-4043, 2005
2492005
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy
SF Shariat, PI Karakiewicz, R Ashfaq, SP Lerner, GS Palapattu, RJ Cote, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
2282008
The role of sarcosine metabolism in prostate cancer progression
AP Khan, TM Rajendiran, A Bushra, IA Asangani, JN Athanikar, ...
Neoplasia 15 (5), 491-IN13, 2013
2172013
Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis
TR Kumar, G Palapattu, P Wang, TK Woodruff, I Boime, MC Byrne, ...
Molecular endocrinology 13 (6), 851-865, 1999
2151999
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression
N Putluri, A Shojaie, VT Vasu, SK Vareed, S Nalluri, V Putluri, ...
Cancer research 71 (24), 7376-7386, 2011
2112011
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder
CG Rogers, GS Palapattu, SF Shariat, PI Karakiewicz, PJ Bastian, Y Lotan, ...
The Journal of urology 175 (6), 2048-2053, 2006
2102006
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
N Amara, GS Palapattu, M Schrage, Z Gu, GV Thomas, F Dorey, J Said, ...
Cancer research 61 (12), 4660-4665, 2001
2052001
Precystectomy nomogram for prediction of advanced bladder cancer stage
PI Karakiewicz, SF Shariat, GS Palapattu, P Perrotte, Y Lotan, CG Rogers, ...
European urology 50 (6), 1254-1262, 2006
1892006
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy
ME Nielsen, SF Shariat, PI Karakiewicz, Y Lotan, CG Rogers, GE Amiel, ...
European urology 51 (3), 699-708, 2007
1722007
Molecular biomarker in prostate cancer: the role of CpG island hypermethylation
PJ Bastian, S Yegnasubramanian, GS Palapattu, CG Rogers, X Lin, ...
European urology 46 (6), 698-708, 2004
1692004
Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
GS Palapattu, C Wu, CR Silvers, HB Martin, K Williams, L Salamone, ...
The Prostate 69 (7), 787-798, 2009
1652009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20